Curaleaf Reports Second Quarter 2023 Results

Second quarter 2023 revenue of $339 million, representing an increase of 4% year-over-year, and adjusted EBITDA(1) of $70 million

Related Keywords

Oregon ,United States ,Pennsylvania ,Illinois ,Florida ,Germany ,Canada ,Deseret ,Utah ,Massachusetts ,Nevada ,Michigan ,New York ,Maine ,Ohio ,Colorado ,Portugal ,Arizona ,Maryland ,Connecticut ,New Jersey ,Canadian ,Tracy Brady ,Matt Darin ,Boris Jordan ,Camilo Lyon ,Curaleaf Holdings Inc ,Corporate Communications ,Drug Administration ,Company Annual Information Form ,Curaleaf International ,Canadian Securities Exchange ,Prnewswire Curaleaf Holdings Inc ,Company Annual Management Discussion ,Curaleaf Holdings ,Executive Chairman ,Chief Executive Officer ,Months Ended June ,Deseret Wellness ,Second Quarter ,Clever Leaves ,Second Quarter Ended June ,Six Months Ended June ,Cash Flow From ,Gross Profit ,Continuing Operations ,Adjusted Gross Profit ,Net Loss ,Cash Flow ,Interim Consolidated Statements ,Cash Flows ,Relations Website ,Chief Investment ,United States Federal Controlled Substances Act ,Annual Information Form ,Annual Management ,Cnsx Cura ,Tc Pink Curlf ,Openhagen Cura ,Tc Bb Curlf ,Tcqx Curlf ,Therotc Curlf ,North East ,United States Of America ,North America ,Inance ,He Economy ,Rade ,Accounting ,Business ,